Tonix Pharmaceuticals to Participate in BIO Investor Forum Digital
CHATHAM, N.J., Oct. 07, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage […]
Mondelēz International Invests in Global Center for Sustainable Cocoa Farming Solutions
Cocoa is at the heart of chocolate and demand is growing, with Asia set to become the second largest consumer […]
AGTC Joins the My Retina Tracker® Program as a New Scientific Collaborator
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Oct. 07, 2020 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation […]
Visteon to Announce Third-Quarter 2020 Results on Thursday, Oct. 29
VAN BUREN TOWNSHIP, Mich., Oct. 07, 2020 (GLOBE NEWSWIRE) — Visteon Corporation (Nasdaq: VC) plans to release its third-quarter 2020 […]
Kamada Provides Update on 2021 GLASSIA® Supply to Takeda
Kamada Expects to Receive $25 Million in Revenues from Sales of GLASSIA® to Takeda in 2021 which is Takeda’s Minimum […]
Tenable and the Center for Internet Security Enter Partnership to Bolster Cyber Hygiene Across Public and Private Sectors
New partnership helps resource-constrained organizations improve their foundational cybersecurity practices, understand their exposure and improve basic cyber hygieneCOLUMBIA, Md., Oct. […]
September 2020’s Most Wanted Malware: New Info-stealing Valak Variant Enters Top 10 Malware List For First Time
SAN CARLOS, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) — Check Point Research, the Threat Intelligence arm of Check Point® Software […]
Scilex Holding Company, a Subsidiary of Sorrento Therapeutics, Announces Continuous Sales Growth in ZTlido® and Expects to Complete Enrollment on its SP-102 (SEMDEXA™) Phase 3 Pivotal Trial Program in 2020
Preliminary Q3 2020 net sales of ZTlido® of approximately $7.2 million, quarter-over-quarter growth of 26% compared to $5.7MM in Q2-2020 […]
Pluristem Expands its Phase II COVID-19 European Clinical Trial to Israel
HAIFA, Israel, Oct. 07, 2020 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a […]
TLC Receives Australian and Taiwan Approval to Initiate Phase I Clinical Trial of TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Oct. 07, 2020 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage […]
